San Diego startup DTx Pharma, which is developing technology for delivering RNA-based therapies to hard-to-treat diseases, has been acquired by drug giant Novartis for $500 million. Founded in ...

For Novartis, the acquisition of DTx comes just a month after the Swiss drugmaker handed over a far larger sum, $3.2 billion, to buy Chinook Therapeutics for a pair of late-stage programs ...

USANA Health Sciences, Inc. (NYSE: USNA), a global nutritional supplement company, today announced that it has filed two new U.S. patents on its popular liver health supplement, Hepasil .